Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Support is delivered through the app, which is a strong point if youre already comfortable with Nooms interface
Pomegranate Sometimes added for an antioxidant/superfood angle, not central to weight-loss claims
Below research-grade, quality becomes unpredictable
Many achieve their goals at the standard tier
The cardiovascular outcome studies under way for incretin-based medications (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation [LEADER] with liraglutide [clinicaltrials.gov, NCT01179048] [27], Exenatide Study of Cardiovascular Event Lowering [EXCSEL] with exenatide once weekly [NCT01144338], Trial Evaluating Cardiovascular Outcomes with Sitagliptin [TECOS] with sitagliptin [NCT00790205], Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus [SAVOR-TIMI 53] with saxagliptin [NCT01107886] [28], and Cardiovascular Outcome Study of Linagliptin versus Glimepiride in Patients with Type 2 Diabetes (CAROLINA) with linagliptin [NCT01243424]) will help in that respect, although the number of events from a single trial will probably be too low for definite answers
US$ 20.67
US$ 24.31
US$ 26.02
US$ 20.86
US$ 21.86
